Arnaud Boyer

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

Vincent Dubée, Pierre‐Marie Roy, Bruno Vielle et al. · Clinical Microbiology and Infection · 2021 · 43 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Effect of Prone Positioning on the Respiratory Support of Nonintubated Patients With COVID-19 and Acute Hypoxemic Respiratory Failure

Eloi Prud’Homme, Youssef Trigui, Xavier Elharrar et al. · CHEST Journal · 2021 · 41 citations · Full text

Medicine, Internal Medicine, Pulmonary Function Testing +16

Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study

L. Falchero, Florian Guisier, Marie Darrason et al. · Lung Cancer · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non‐Small Cell Lung Carcinoma

D Imbs, Raouf El Cheikh, Arnaud Boyer et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer

Benjamin Schneider, Arnaud Boyer, Joseph Ciccolini et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16